Abstract
The enforcement of the Medical Devices Regulation (MDR) began in the European Union (EU) in May 2021. Under MDR, software and information systems may be considered as medical devices. Behaviour Change Support Systems (BCSS) are information and communication technologies aimed at helping their users to achieve behaviour change targets. Designers, developers, and researchers of health BCSS (hBCSS) need to understand the impact of this new regulation on the development of such systems as the regulation influences both design and development in a variety of ways. Furthermore, myriads of health BCSS have been developed previously in the medical, fitness, and wellbeing domains, and a substantial number of them may require qualification, classification, or reclassification as medical devices under the new regulation. However, the regulation process is complex and requires knowledge and expertise which many manufacturers do not have in-house. Depending on the context and classification, the costs may suddenly ramp up and become too much for smaller developers, and thus they should be carefully assessed. In this paper, we discuss the regulation from the point of view of hBCSS developers. We look at the regulatory process and highlight key issues for developers of hBCSS. Particular attention is given to the classification and design requirements most likely to pose immediate challenges to developers. In addition, we discuss the costs associated with MDR which are difficult to estimate without previous experience.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Melvin, T., Torre, M.: New medical device regulations: the regulator’s view. EFORT Open Rev. 4(6), 351–356 (2019). https://doi.org/10.1302/2058-5241.4.180061
IQVIA: Digital Health Trends 2021 - Innovation, Evidence, Regulation, and Adoption (2021)
Keutzer, L., Simonsson, U.S.H.: Medical device apps: an introduction to regulatory affairs for developers. JMIR mHealth uHealth 8(6), e17567 (2020). https://doi.org/10.2196/17567
Cohen, D.: Devices and desires: industry fights toughening of medical device regulation in Europe. BMJ 347(7929), f6204 (2013). https://doi.org/10.1136/BMJ.F6204
The Council of the European Communities: COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices (1993)
The European Commission: New EU rules to ensure safety of medical devices, https://ec.europa.eu/commission/presscorner/detail/en/MEMO_17_848. Accessed 28 Nov 2021
Cohen, D.: How a fake hip showed up failings in European device regulation. BMJ 345(7880), e7090 (2012). https://doi.org/10.1136/BMJ.E7090
Martindale, V., Menache, A.: The PIP scandal: an analysis of the process of quality control that failed to safeguard women from the health risks. J. R. Soc. Med. 106(5), 173 (2013). https://doi.org/10.1177/0141076813480994
Heneghan, C., Aronson, J.K., Goldacre, B., Mahtani, K.R., Plüddemann, A., Onakpoya, I.: Transvaginal mesh failure: lessons for regulation of implantable devices. BMJ 359, j5515 (2017). https://doi.org/10.1136/BMJ.J5515
The European Parliament and the Council: Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EE (2017)
Maresova, P., Rezny, L., Peter, L., Hajek, L., Lefley, F.: Do regulatory changes seriously affect the medical devices industry? Evidence from the Czech Republic. Front. Public Health 9, 415 (2021). https://doi.org/10.3389/FPUBH.2021.666453
Leo, H.: MDR Guide for Medical Device Software. Guide.pdf (2021). https://www.fme.nl/system/files/publicaties/2021-09/MDR
Oinas-Kukkonen, H., Harjumaa, M.: Persuasive systems design: key issues, process model, and system features. Commun. Assoc. Inf. Syst. 24(1), 485–500 (2009). https://doi.org/10.17705/1cais.02428
The European Commission: Notified bodies. https://ec.europa.eu/growth/single-market/goods/building-blocks/notified-bodies_en. Accessed 28 Nov 2021
The European Commission: Introduction to the new UDI system and the obligations of operators. https://ec.europa.eu/health/system/files/2020-09/md_faq_udi_en_0.pdf. Accessed 28 Nov 2021
The European Commission: Medical Devices - EUDAMED – Overview. https://ec.europa.eu/health/md_eudamed/overview_en. Accessed 28 Nov 2021
The European Commission: Transition Timelines from the Directives to the Regulations Medical Devices and in vitro Diagnostic Medical Devices. https://ec.europa.eu/health/sites/default/files/md_newregulations/docs/md_infographic-timeline_en.pdf. Accessed 30 Nov 2021
The European Commission: Market surveillance and vigilance. https://ec.europa.eu/health/md_sector/market-surveillance-and-vigilance_en. Accessed 28 Nov 2021
The European Union Medical Device Regulation: What’s changed compared to the MDD. https://eumdr.com/whats-changed/. Accessed 15 Nov 2021
MDR Rule 11: The Classification Nightmare. https://www.johner-institute.com/articles/regulatory-affairs/and-more/mdr-rule-11-software/. Accessed 15 Nov 2021
Working Group on Borderline and Classification for Consultation: Manual on Borderline and Classification in the Community Regulatory Framework for Medical Device. https://ec.europa.eu/health/system/files/2020-08/md_borderline_manual_05_2019_en_0.pdf. Accessed 15 Nov 2021
The European Commission: Factsheet for manufacturers of medical device. https://ec.europa.eu/docsroom/documents/31201. Accessed 29 Nov 2021
The European Commission: Step by step implementation model for Medical Device Regulation. https://ec.europa.eu/docsroom/documents/30905. Accessed 29 Nov 2021
The European Commission: Commission Implementing Regulation (EU) 2020/1207 of 19 August 2020 laying down rules for the application of Regulation (EU) 2017/745 of the European Parliament and of the Council as regards common specifications for the reprocessing of single-use devices (2020)
MDCG: Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745 – MDR and Regulation (EU) 2017/746 – IVDR (2019)
EC certificate for Natural Cycles Nordic AB (2017). https://www.datocms-assets.com/21281/1610371680-ec-certificate-natural-cycles.pdf
Natural Cycles Science: Digital Birth Control Explained. https://www.naturalcycles.com/the-science. Accessed 16 Nov 2021
The Corona App - first example of MDR Class I Software? https://www.qservegroup.com/eu/en/i601/the-corona-app---first-example-of-mdr-class-i-software. Accessed 28 Nov 2021
European Medicines Agency: Qualification opinion on ingestible sensor system for medication adherence as biomarker for measuring patient adherence to medication in clinical trials (2016)
The first Clinically Validated AI-powered Diabetes Assistant. https://cordis.europa.eu/project/id/866147. Accessed 30 Nov 2021
Establishment Registration & Device Listing. https://www.accessdata.fda.gov/scrIpts/cdrh/cfdocs/cfRL/rl.cfm?lid=506280&lpcd=MDS. Accessed 21 Nov 2021
Climedo Health GmbH: EU MDR Readiness Check 2021 Survey Results. https://climedo.de/wp-content/uploads/2021/04/EU-MDR-Survey-Results-2021-EN.pdf?utm_campaign=MDRReadinessSurvey2021&utm_medium=email&_hsmi=160180699&_hsenc=p2ANqtz-9guQk5HUjqBqFL8BoO-UTvuDIxOhrrICwXXUe7_ixx1tPySJpZdxqWpqNHKQKbf53uMcsxUsxZDcYjkA-bh4aq98. Accessed 30 Nov 2021
Peter, L., Hajek, L., Maresova, P., Augustynek, M., Penhaker, M.: Medical devices: regulation, risk classification, and open innovation. J. Open Innov. Technol. Market Complex. 6(2), 42 (2020). https://doi.org/10.3390/JOITMC6020042
Climedo Health GmbH: EU MDR Survey - The True Cost of the New Regulation. https://climedo.de/wp-content/uploads/2021/02/2020_EUMDR_Costs_SurveyResults_EN.pdf?utm_campaign=2020EUMDRCostsSurvey&utm_medium=email&_hsmi=160180201&_hsenc=p2ANqtz-8AF7kI9HlCbIbbFDDqk6wJL4yEsxFJIqNRffKUPq7_c0pYdyUTSifbv3CNKf5S0u2XO2imes1Jub67FXkb4Ql. Accessed 28 Nov 2021
Maresova, P., Hajek, L., Krejcar, O., Storek, M., Kuca, K.: New regulations on medical devices in Europe: are they an opportunity for growth? Adm. Sci. 10(1), 16 (2020). https://doi.org/10.3390/ADMSCI10010016
Porter, M.E.: America’ green strategy. In: Welford, R., Starkey, R. (eds.) Business and the Environment: A Reader, pp. 33–35. Taylor & Francis, Washington DC (1996)
Thirumalai, S., Sinha, K.K.: Product recalls in the medical device industry: an empirical exploration of the sources and financial consequences. Manage. Sci. 57(2), 376–392 (2011). https://doi.org/10.1287/MNSC.1100.1267
Guerra-Bretaña, R.M., Flórez-Rendón, A.L.: Impact of regulations on innovation in the field of medical devices. Res. Biomed. Eng. 34(4), 356–367 (2018). https://doi.org/10.1590/2446-4740.180054
Acknowledgment
We are grateful to Ilona Santavaara for commenting and Dr. Piiastiina Tikka of the OASIS research unit for proofreading this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this paper
Cite this paper
Agyei, E.E.Y.F., Pohjolainen, S., Oinas-Kukkonen, H. (2022). Impact of Medical Device Regulation on Developing Health Behavior Change Support Systems. In: Baghaei, N., Vassileva, J., Ali, R., Oyibo, K. (eds) Persuasive Technology. PERSUASIVE 2022. Lecture Notes in Computer Science, vol 13213. Springer, Cham. https://doi.org/10.1007/978-3-030-98438-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-98438-0_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-98437-3
Online ISBN: 978-3-030-98438-0
eBook Packages: Computer ScienceComputer Science (R0)